title: Lower limbs erosions induced by sunitinib.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Kluger
authors.forename: Angélique
authors.initials: A
authors.lastname: Chapelle
authors.forename: William
authors.initials: W
authors.lastname: Jacot
authors.forename: Bernard
authors.initials: B
authors.lastname: Guillot
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000556:secondary; D016523:Foot Ulcer / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D006225:Hand; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D058990:Molecular Targeted Therapy / Q000009:adverse effects; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011758:Pyrroles / Q000009:adverse effects*; D012883:Skin Ulcer / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D000077210:Sunitinib; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D020533:Angiogenesis Inhibitors; D000891:Anti-Infective Agents, Local; D007211:Indoles; D047428:Protein Kinase Inhibitors; D011758:Pyrroles; D000077210:Sunitinib